Author

Ray G. Crispen

Observed names: R Crispen, R G Crispen, R. Crispen, R. G. Crispen, R.G. Crispen, RAY CRISPEN, Ray Crispen, RayG. Crispen

Observed institutions: Northwestern University, West Virginia University, University of Illinois Urbana-Champaign, The University of Texas at San Antonio Health Science Center, John H. Stroger, Jr. Hospital of Cook County, West Virginia University Hospitals, University of Illinois Chicago, Hektoen Institute, Cook County Health and Hospitals System

OpenAlex ID: A5000620280

Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder Cancer

1986 · Donald L. Lamm, Valerie D. Stogdill, et al. · The Journal of Urology · 387

Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation

1986 · T J Holzer, K E Nelson, et al. · Infection and Immunity · 82

Tuberculosis in physicians. Compliance with preventive measures.

1987 · P J Geiseler, K E Nelson, et al. · PubMed · 43

History of BCG and its substrains.

1989 · R Crispen · PubMed · 35

Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis.

1981 · M M Yokoyama, Y Matsui, et al. · PubMed · 34

A Randomized Prospective Comparison of Oral Versus Intravesical and Percutaneous Bacillus Calmette-guerin for Superficial Bladder Cancer

1990 · Donald L. Lamm, Jean I. DeHaven, et al. · The Journal of Urology · 21

Adjuvant immunotherapy with bacillus Calmette-Guérin in prostatic cancer

1979 · P. Guinan, G. Baumgartner, et al. · Urology · 15

BCG Vaccination and Leukemia Mortality

1974 · S. R. Rosenthal, R. G. Crispen, et al. · Recent results in cancer research/Recent Results in Cancer Research · 14

Rapid testing of freeze dried bcg vaccine for stability and viability

1971 · Ray G. Crispen · 14

Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer.

1983 · J A Bennett, H Gruft, et al. · PubMed · 13

BCG vaccine in perspective.

1974 · R G Crispen · PubMed · 13

BCG vaccination and cancer mortality

1976 · R. G. Crispen, S. R. Rosenthal · Cancer Immunology Immunotherapy · 12

BCG in management of superficial bladder cancer

1987 · Patrick Guinan, Ray Crispen, et al. · Urology · 9

Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma.

1978 · A A El-Domeiri, T K Das Gupta, et al. · PubMed · 3

BCG and cancer.

1986 · R G Crispen · PubMed · 2

Prostate carcinoma: immunostaging and adjuvant immunotherapy with BCG.

1978 · P D Guinan, T John, et al. · PubMed · 2

Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.

1978 · S E Warren, R G Crispen, et al. · PubMed · 1

BCG vaccine. Past, present, future.

1976 · R G Crispen · PubMed · 1

Immunotherapy With Intravenous B.c.g.

1974 · RayG. Crispen · The Lancet · 1

Natural Killer Cell Activity as Independent Prognostic Indicator of Survival in Advanced Colon Cancer Patients

1994 · R G Crispen, W L Simonich, et al. · Journal of Immunotherapy

Natural Killer Cell Activity Is Independent Prognostic Factor in Metastatic Non-small Cell Lung Cancer With Good Performance Status

1994 · R. G. Crispen, W. L. Simonich, et al. · Journal of Immunotherapy

Qualitative effect of BCG vaccination on sensitivity to typical and atypical tuberculins.

1986 · R G Crispen · PubMed

Re: Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma

1984 · Ray G. Crispen · The Journal of Urology

Cancer--etiology and prevention : proceedings of the Chicago Symposium on Cancer--Etiology and Prevention, Chicago, Illinois, U.S.A., October 4-6, 1982

1983 · Ray G. Crispen · Elsevier eBooks

BCG vaccine and other measures to prevent tuberculosis in physicians

1982 · P. Jan Geiseler, Kenrad E. Nelson, et al. · Clinical research

Works count: 31

Citation count: 702

H-index: 12

I10-index: 12